课题基金 / 基金详情

Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
开发 SARS-CoV-2 肽治疗药物和用于快速病毒检测的护理点唾液诊断
批准号:
429204
负责人:
Babu Mohan
金额:
$68.33万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-05-01 至 2021-05-01

项目摘要

项目成果

Babu Mohan的其他基金

相关文献

中文摘要
翻译
SARS-CoV-2 (COVID-19的病原体)构成了一代人的威胁,迄今为止还没有获得许可的疫苗或有效的治疗方法。此外,缺乏可靠的诊断,特别是在检测无症状/轻度症状病例时,这是一个严重的问题
英文摘要
SARS-CoV-2 (the causative agent of COVID-19) poses a generational threat, with no licensed vaccines or effective therapies to date. Further, the scarcity in reliable diagnostics, especially when testing asymptomatic/mildly symptomatic cases, is of grave c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering Mitochondrial Interplay in Bipolar Disorder
  • 批准号:
    469054
  • 项目类别:
    Operating Grants
  • 资助金额:
    $68.55万
  • 财政年份:
    2022
  • 负责人:
    Babu Mohan
  • 依托单位:
COVID-19 Variant Network - Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
  • 批准号:
    443334
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Babu Mohan
  • 依托单位:
COVID-19 Variant Supplement - Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
  • 批准号:
    443198
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Babu Mohan
  • 依托单位:
Targeting the Mammalian Mitochondrial Interactome to Dissect Macromolecular Assemblies and Pathways in Health and Disease
  • 批准号:
    354936
  • 项目类别:
    Operating Grants
  • 资助金额:
    $144.06万
  • 财政年份:
    2016
  • 负责人:
    Babu Mohan
  • 依托单位: